Abstract:Objective To investigate the correlation between the levels of placenta growth factor (PLGF),soluble angiopoietin receptor-2 (sTie-2) and critical coronary artery plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease (CHD).Methods In three consecutive years from April 2007 to September 2009,a cohort of 719 patients with borderline coronary lesions with stenosis in three main vessels with lumen diameter reduction varied all the way from more than 20％ to less than 70％ and with greater than 2.25 mm of the inner diameter were selected in this study from 4 teaching hospitals of tertiary class A in Beijing.These patients fell into three categories:unstable angina pectoris (UAP,n =292),stable angina pectoris (SAP,n =219) and coronary arteriosclerosis (AS,n =208).The vessels involved were analyzed using quantitative coronary angiography (QCA).Plasma levels of PLGF and sTie-2 were measured by using protein chip.The relationship between plasma levels of vascular factors,sTie-2,PLGF and coronary artery plaque imaging morphology among three groups were analyzed.Results (1) Plasma level of PLGF was 80.33 ng/L in the UAP group,which was significantly higher than 54.29 ng/L in the SAP group and 45.16 ng/L in AS group (both P ＜0.05).Plasma level of sTie-2 was 1353.06 ng/L in the UAP group,which was significantly higher than 1308.28 ng/L in the AS group (P =0.008).(2) There was significantly statistical differences in QCA between the SAP group and the UAP group as well as the AS group (both P ＜ 0.05) in terms of the minimal lumen diameter,diameter stenosis rate,minimal lumen cross-sectional area and cross-sectional area of stenosis.The plaque area in the UAP group was larger than that in the AS group (P =0.013).(3) The relationship between vascular factors and plaque imaging morphology was analyzed.There was significantly statistical difference in the involved lesions among the three groups (P ＜ 0.01).(4) There was a positive correlation between plasma level of PLGF and minimal lumen cross-sectional area (r =0.493,P =0.009).Conclusions The plasma levels of PLGF and sTie-2 reflect the level of neo-vascularization in the plaque,and could be taken as predictive factors for potential pathogenesis of coronary plaque.

Detection and Significance of Plasma Placental Growth Factor in Patients with Premature Coronary Heart Disease

[Detection of Plasma Level of Placental Growth Factor from Patients with Coronary Artery Disease].

Roles of placental growth factor in percutaneous coronary angioplasty and stent implantation]

A study in the correlation between vascular factors and plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Growth differentiation factor 15, ischemia modified albumin and pregnancy-associated plasma protein A in patients with coronary artery disease

Clinical significance of D-dimer and fibrinogen in early diagnosis of coronary heart disease

Determination and Clinical Significance of Plasma Fibrinogen, Lipoprotein (a) and Platelet Parameters in Coronary Heart Disease

Analysis of Placental Growth Factor in Placentas of Normal Pregnant Women and Women with Hypertensive Disorders of Pregnancy

Circulating miR-214 level and its correlation with the extent of coronary lesion in patients with acute myocardial infarction

[Relationship Between Placenta Growth Factor and the Pathogenesis of Pregnancy Induced Hypertension Syndrome].

Levels Of Pregnancy-Associated Plasma Protein A In Patients With Coronary Artery Disease

The prediction value of platelet-derived growth factor for major adverse cardiovascular events in patients with acute non-ST-segment elevation myocardial infarction

Study on pathogenesis of plasma coagulation factors on coronary heart disease

Value of a ratio of sFlt-1 to PLGF in prospecting the preeclampsia

Relationships of plasma C-reactive protein with clinical phenotypes and coronary artery lesions in patients with premature coronary heart disease

Peripheral blood markers in detection of vulnerable coronary atherosclerotic plaque

Lipoprotein Lipase And Premature Coronary Artery Disease

Study on Gene Polymorphism and Activity of Lipoprotein Lipase and Its Relation to Serum Lipids in Patients with Premature Coronary Heart Disease

Related Change and Its Clinical Significance of Platelet Parameters in Patients with Coronary Heart Disease and Premature Ventricu-lar Premature

Variations of placental growth factor and its receptor Fit-1 before and after cardiopulmonary bypass